LOGIN
RA: Addition of etanercept to methotrexate increases remission rates
April 2013
RA: Addition of etanercept to methotrexate increases remission rates
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial
Lancet. 2008 Aug 2;372(9636):375-82. Epub 2008 Jul 16Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
542 patients with adult-onset rheumatoid arthritis were randomized to either receive a combination treatment of both etanercept and methotrexate, or just treatment with methotrexate. The results at 1 year indicated that the combination of etanercept and methotrexate resulted in high remission rates and was effective in arresting radiographic progression of joint damage.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.